Trovafloxacin is active against Toxoplasma gondii.
Drugs currently used for treatment of toxoplasmosis in pregnant women, congenital infections, immunocompromised patients, and patients with the ocular disease are not always effective or may be dangerous to use; therefore, there is a need for more-effective and less-toxic drugs. Recently, we examine...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1996
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163429/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8843293/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.8.1855 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|